Morning Overview on MSN
New gene-editing method targets cancer DNA while sparing healthy cells
Most gene-editing tools cut DNA wherever they’re pointed, with no way to tell a tumor cell from a healthy one. A study ...
Serious fungal infections are on the rise, and many hospital-acquired cases are becoming harder to treat as fungi become ...
Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib compared to ...
A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance ...
New findings suggest a way to disarm resistant bacteria, making existing antibiotics effective and improving treatment options for people with hard-to-treat infections.
We are pleased to welcome Drew to the Trethera Board,” said Dr. Ken Schultz, Chairman and Chief Executive Officer of Trethera. “Drew brings a unique combination of legal, strategic, and operational ...
In this retrospective analysis, Zil-E-Ali et al found that patients with government-funded insurance who underwent urgent or ...
New in vivo data demonstrate exceptional selectivity, localization and potency of MDNA113 in the tumor and tumor microenvironment while enhancing ...
A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance and a process known as ...
This study characterizes several novel activities of SARS-CoV-2 helicase nsp13, providing valuable insights into potentially new functions of this essential RNA-processing enzyme in the virus life ...
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced data from a benchmark ...
Celery contains nutrients and plant compounds that naturally lower blood pressure by dilating blood vessels and serving as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results